Development of SARS-CoV-2 IgM and IgG antibodies in a Relapsing Multiple Sclerosis patient on Ofatumumab

Publication date: Available online 19 January 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Ramon E Flores-Gonzalez, Jeffrey Hernandez, Leticia Tornes, Kottil Rammohan, Silvia Delgado
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research